Advertisement

Archives of Gynecology and Obstetrics

, Volume 277, Issue 1, pp 67–69 | Cite as

Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine

  • V. Schwarzer
  • A. Heep
  • U. Gembruch
  • A. RohdeEmail author
Case Report

Abstract

Here we present the case of a 30-year-old woman with type I diabetes mellitus, preeclampsia and treatment resistant persistent hyperemesis gravidarum in her 25th week of gestation who was successfully treated with the antidepressant mirtazapine (Remergil©). Nausea and vomiting resolved within 5 days. After discharge from the hospital in 28 weeks of gestation and discontinuation of the medication on her own initiative a relapse occurred, once again with good response to mirtazapine. The drug was continued until birth. At 34 + 0 weeks a cesarian section was performed due to fetal growth restriction and deteriorating preecplampsia. During the second and fourth day postnatal age the child temporarily developed hyperarousal which could be explained by mirtazapine withdrawal.

Keywords

Antidepressant Diabetes mellitus Hyperemesis gravidarum Mirtazapine Mirtazapine withdrawal 

References

  1. 1.
    ACOG Practice Bulletin (2004) Nausea and vomiting of pregnancy. Obstet Gynecol 103:803–814Google Scholar
  2. 2.
    Berigan TR (2001) Mirtazapine-associated withdrawal symptoms: a case report. Primary Care Companion. J Clin Psychiatry 3:143Google Scholar
  3. 3.
    Broocks A, Junghanns K, Thiel A, Gleiter CH, Bandelow B (2000) New antidepressive drugs in comparison with classical tricyclics. Mechanism of action and clinical evaluation. Fortschr Neurol Psychiatr 68:17–24PubMedCrossRefGoogle Scholar
  4. 4.
    Buckwalter JG, Simpson SW (2002) Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy. Am J Obstet Gynecol 186:210–214CrossRefGoogle Scholar
  5. 5.
    Dorn C, Pantlen A, Rohde A (2002) Mirtazapin (Remergil©). Behandlungsoption bei therapieresistenter Hyperemesis gravidarum?—ein Fallbericht. Geburtsh Frauenheilk 62:1–4CrossRefGoogle Scholar
  6. 6.
    Eroglu A, Kurkcuoglu C, Karaoglanoglu N, Tekinbas C, Cesur M (2002) Spontaneous esophageal rupture following severe vomiting in pregnancy. Dis Esophagus 15:242–243PubMedCrossRefGoogle Scholar
  7. 7.
    Gentile S (2005) The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf 28:137–152PubMedCrossRefGoogle Scholar
  8. 8.
    Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM (1992) The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 75:1333–1337PubMedCrossRefGoogle Scholar
  9. 9.
    Goodwin TM, Montoro M, Mestman JH (1992) Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 167:648–652PubMedGoogle Scholar
  10. 10.
    Goodwin TM (1998) Hyperemesis gravidarum. Clin Obstet Gynecol 41:597PubMedCrossRefGoogle Scholar
  11. 11.
    Guclu S, Gol M, Dogan E, Saygili U (2005) Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature. Arch Gynecol Obstet 272:298–300PubMedCrossRefGoogle Scholar
  12. 12.
    Jarnfelt-Samisioe A, Erikson B, Waldenstrom J, Samisioe G (1985) Some new aspects on emesis gravidarum. Relations to clinical data, serum electrolytes, total protein and creatinine. Gynecol Obstet Invest 19:174–186CrossRefGoogle Scholar
  13. 13.
    Kim YH, Lee SJ, Rah SH, Lee JH (2002) Wernicke´s encephalopathy in hyperemesis gravidarum. Cab J Opthalmol 37:37–38Google Scholar
  14. 14.
    Klebanoff MA, Koslowe PA, Kaslow R, Rhoads GG (1985) Epidemiology of vomiting in early pregnancy. Obstet Gynecol 66:612–616PubMedGoogle Scholar
  15. 15.
    Kocak I, Akcan Y, Ustun C, Demirel C, Cengiz L, Yanik FF (1999) Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. Int J Gynaecol Obstet 66:251–254PubMedCrossRefGoogle Scholar
  16. 16.
    Levicheck Z, Atanackovic G, Oepkes D, Meltepe C, Einarson A, Magee L (2002) Nausea and vomiting of pregnancy. Evidence-based treatment algorithm. Can Fam Physician 48:267–277Google Scholar
  17. 17.
    Montgomery SA (1995) Safety of mirtazapine: a review. Int Clin Psychopharmacol 10([Suppl]):37–45PubMedCrossRefGoogle Scholar
  18. 18.
    Rohde A, Dembinski J, Dorn C (2003) Mirtazapin (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy. Arch Gynecol Obstet 268:219–221PubMedCrossRefGoogle Scholar
  19. 19.
    Saks B (2001) Mirtazapine: treatment of depression, anxiety, and hyperemesis gravidarum in the pregnant patient. A report of 7 cases. Arch Womens Ment Health 3:165–170CrossRefGoogle Scholar
  20. 20.
    Simpson SW, Goodwin TM, Robins SB, Rizzo AA, Howes RA, Buckwalter DK et al (2001) Psychological factors and hyperemesis gravidarum. J Women´s Health Gend Based Med 10:471–477CrossRefGoogle Scholar
  21. 21.
    Spruill SC, Kuller JA (2002) Hyperemesis gravidarum complicated by Wernicke´s encephalopathy. Obstet Gynecol 99:875–877PubMedCrossRefGoogle Scholar
  22. 22.
    Tierson FD, Olsen CL, Hook EB (1986) Nausea and vomiting of pregnancy and association with pregnancy outcome. Am J Obstet Gynecol 155:1017PubMedGoogle Scholar
  23. 23.
    Togay-Isikay C, Yigit A, Mutluer N (2001) Wernicke´s encephalopathy due to hyperemesis gravidarum: an under-recognized condition. Aust N Z J Obstet Gynecol 41:453–456Google Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Department of Obstetrics and Prenatal MedicineUniversity Clinics of BonnBonnGermany
  2. 2.Department of NeonatologyUniversity Clinics of BonnBonnGermany
  3. 3.Department of Psychosomatics in GynecologyUniversity Clinics of BonnBonnGermany

Personalised recommendations